Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

CG Oncology Inc.

Contributing Author

Recent Articles by CG Oncology Inc.

Sep-02
CG Oncology to Present at Upcoming Investor Conferences in September CGON GlobeNewswire
Aug-06
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates CGON GlobeNewswire
Jul-27
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology CGON +6.06% GlobeNewswire
May-28
CG Oncology to Present at Upcoming Investor Conferences in June CGON GlobeNewswire
May-19
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award CGON GlobeNewswire
May-15
CG Oncology Reports Positive First Results from CORE-008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients CGON GlobeNewswire
May-11
CG Oncology's Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC CGON GlobeNewswire
May-08
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates CGON GlobeNewswire
May-05
CG Oncology to Present at Upcoming Investor Conferences in May CGON GlobeNewswire
Feb-27
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates CGON GlobeNewswire
Feb-23
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference CGON GlobeNewswire
Jan-09
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC CGON +29.26% GlobeNewswire
Jan-06
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference CGON GlobeNewswire
Dec-18
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award CGON GlobeNewswire
Dec-05
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer CGON GlobeNewswire
Nov-26
CG Oncology Announces New Board Member and Board Transition CGON GlobeNewswire
Nov-25
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting CGON GlobeNewswire
Nov-14
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates CGON +8.61% GlobeNewswire
Sep-05
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months CGON +6.88% GlobeNewswire
Sep-03
CG Oncology Completes Enrollment in PIVOT-006 CGON GlobeNewswire
Aug-29
CG Oncology's Executive Leadership to Participate in Upcoming Investor Conferences CGON GlobeNewswire
Aug-08
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates CGON GlobeNewswire
Jul-29
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals CGON GlobeNewswire
Jun-05
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference CGON GlobeNewswire
May-15
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference CGON GlobeNewswire
May-13
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates CGON GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)